Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  CYANOTECH CORP    CYAN

SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsSector newsTweets

CYANOTECH : Michael A. Davis Named Chairman of the Board of Directors of Cyanotech

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2011 | 02:10pm CET

Michael A. Davis has been elected as Chairman of the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). He replaces Gregg Robertson, who resigned in late 2010.

Mr. Davis was Vice-Chairman of the Board and has been a Director of Cyanotech since March 2003.

"Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years," said Brent Bailey, President and CEO. "We look forward to his continuing support and leadership as Chairman of the Board."

Mr. Davis, a private Investor and major shareholder of Cyanotech since 1994, is also President of Skywords Family Foundation and a Director of Canobie Films, Inc.

About Cyanotech -- Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®--all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.

Cyanotech Corporation
Bruce Russell, 310-559-4955 x101


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CYANOTECH CORP
11/07 CYANOTECH : earns $475K in second quarter
11/06 CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
11/06 CYANOTECH : Reports Financial Results for the Second Quarter of Fiscal Year 2018
08/25 CYANOTECH CORPORATION (NASDAQ : CYAN) Files An 8-K Submission of Matters to a Vo..
08/25 CYANOTECH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
08/17 CYANOTECH : to Hold Investor Broadcast on Friday, August 11, 2017
08/16 CYANOTECH : Business hatches plan to protect endangered birds
08/12 CYANOTECH : Transcript of August 11 earnings call for Q1 FY 18
08/11 CYANOTECH : enjoys a better first quarter from sales boost
08/10 CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
More news
News from SeekingAlpha
11/10 Cyanotech Corporation's (CYAN) CEO Gerry Cysewski on Q3 2017 Results - Earnin..
11/06 Cyanotech reports Q2 results
08/11 Cyanotech Corporation's (CYAN) CEO Gerry Cysewski on Q1 2018 Results - Earnin..
08/10 Midday Gainers / Losers
08/10 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Chart CYANOTECH CORP
Duration : Period :
CYANOTECH CORP Technical Analysis Chart | CYAN | US2324373016 | 4-Traders
Managers
NameTitle
Gerald R. Cysewski Chief Executive Officer & Director
Mawae Morton President
Michael A. Davis Chairman
Gerard J. Watts Chief Operating Officer
Jolé Eileen Deal CFO, Secretary, Treasurer & VP-Administration
Sector and Competitors
1st jan.Capitalization (M$)
CYANOTECH CORP1.16%0
BIOGEN20.14%65 444
CSL LIMITED41.53%48 909
ALEXION PHARMACEUTICALS-9.38%24 238
GRIFOLS SA33.42%18 723
BIOMARIN PHARMACEUTICAL0.13%14 568